Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: A double-blind randomized control trial of 2 and 5 mg per day for 120 days

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 1, 2002, Pages 63-70

  Brown, Audrey ^a,b   Cheng, Linan ^a,b   Lin, Suiqing ^a,b   Baird, David T ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Shanghai Municipal Key Clinical Specialty   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE;

ADULT; AMENORRHEA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM HYPERPLASIA; FEMALE; HUMAN; HUMAN EXPERIMENT; MENSTRUATION; NORMAL HUMAN; ORAL CONTRACEPTION; OVARY FUNCTION; OVULATION; OVULATION INHIBITION; PRIORITY JOURNAL;

EID: 0036149959     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.1.8140     Document Type: Article

References (23)

1. Science, medicine and the future. Contraception
2. Progestogen only contraception
3. Approval of mifepristone (RU486) in Europe
4. The development of mifepristone: A pharmaceutical drama in three acts
5. Potential contraceptive effects of antigestogens
6. The use of progesterone antagonists and progesterone receptor modulators in contraception
7. Inhibition of ovulation by low dose mifepristone (RU486)
8. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle
9. Effect of daily low dose mifepristone on the ovarian cycle and on the dynamics of follicle growth
10. Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation
11. Effects of long-term low-dose mifepristone on reproductive function in women
12. Contraceptive efficacy of daily administration of 0.5 mg mifepristone
13. A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles
14. Failure of estrogen induced LH surge in women treated with mifepristone (RU486) every day for 30 days
15. Effect of cyclofenil on hormonal dynamics, follicular development and cervical mucus in normal and oligomenorrhoeic women
16. Comparative pharmacokinetics of selected contraceptive steroids in animal species and man
17. Estrogen metabolism and excretion in Oriental and Caucasian women
18. Do urinary metabolites reflect differences in the breast cancer risk between Singapore Chinese and United States African-American and white women?
19. Endometrial effects of long-term low-dose administration of RU486
20. Non-competitive anti-estrogenic actions of progesterone antagonists in primate endometrium; enhancement of estrogen and progesterone receptors with blockade with post-receptor proliferative mechanisms
21. Antiproliferative effects of progesterone antagonists and progesterone receptor modulators on the endometrium
22. Effects of daily low dose mifepristone on endometrial maturation and proliferation
23. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use and hormone replacement therapy use